Literature DB >> 2357095

Categories of preventable unexpected infant deaths.

E M Taylor1, J L Emery.   

Abstract

The conclusions of confidential inquiries into 115 registered unexpected infant deaths over a period of nine years were reviewed. Deaths were classified based on the total information available into group A: poor prognosis (n = 7), group B: treatable disease (n = 45), group C: minor disease (n = 32), group D: no disease (n = 19), group E: probably accidental (n = 4), and group F: probably filicide (n = 8). Less than 20% of deaths corresponded to the classic definition of sudden infant death syndrome (SIDS). Babies who died during the course of potentially treatable disease had more adverse family and social factors: the parents were less likely to be owner occupiers, or own a car or telephone, their mothers were more likely to be young, to smoke, and to present late in pregnancy. Babies who died of minor disease tended to come from similar backgrounds, their families had greater levels of stress and the deaths appeared to be due to more than one factor. Babies who died with no terminal disease were younger, and more likely to be boys. Their families appeared to be demographically similar to those of a control group and to the general population.

Entities:  

Mesh:

Year:  1990        PMID: 2357095      PMCID: PMC1792173          DOI: 10.1136/adc.65.5.535

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Unexpected postneonatal deaths (cot deaths) due to recognizable disease.

Authors:  P M McWeeny; J L Emery
Journal:  Arch Dis Child       Date:  1975-03       Impact factor: 3.791

2.  Trends in unexpected infant deaths in Sheffield.

Authors:  E M Taylor; J L Emery
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

3.  Identification of children at risk of unexpected death.

Authors:  E M Taylor; J L Emery; R G Carpenter
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

4.  Post-perinatal infant mortality in Glasgow 1979-81.

Authors:  G C Arneil; H Brooke; A A Gibson; A Harvie; H McIntosh; W J Patrick
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

5.  Enquiries into infant deaths.

Authors:  S Carne
Journal:  J R Coll Gen Pract       Date:  1983-09

6.  Perinatal mortality surveys.

Authors:  A Macfarlane
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-01

7.  Inquiries into perinatal and early childhood deaths in a health care district.

Authors:  F Brimblecombe; M Bastow; J Jones; N Kennedy; J Wadsworth
Journal:  Arch Dis Child       Date:  1984-07       Impact factor: 3.791

8.  Infant deaths in inner London: a health care planning team study.

Authors:  S R Palmer; R D Wiggins; B R Bewley
Journal:  Community Med       Date:  1980-05

9.  Two-year study of the causes of postperinatal deaths classified in terms of preventability.

Authors:  E M Taylor; J L Emery
Journal:  Arch Dis Child       Date:  1982-09       Impact factor: 3.791

10.  Prevention of unexpected infant death. Evaluation of the first seven years of the Sheffield Intervention Programme.

Authors:  R G Carpenter; A Gardner; M Jepson; E M Taylor; A Salvin; R Sunderland; J L Emery; E Pursall; J Roe
Journal:  Lancet       Date:  1983-04-02       Impact factor: 79.321

  10 in total
  15 in total

1.  Categories of preventable unexpected infant deaths.

Authors:  P J Fleming; P Berry; R Gilbert; J Golding; P T Rudd; E Hall; D White; J Holton
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

2.  Environment of infants during sleep and risk of the sudden infant death syndrome: results of 1993-5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Confidential Enquiry into Stillbirths and Deaths Regional Coordinators and Researchers.

Authors:  P J Fleming; P S Blair; C Bacon; D Bensley; I Smith; E Taylor; J Berry; J Golding; J Tripp
Journal:  BMJ       Date:  1996-07-27

3.  Differences in postperinatal infant deaths between north and southern Derbyshire.

Authors:  M Newlands; E Adamson; S Ghulam; M Saleh; J L Emery
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

4.  The effectiveness of health systems in influencing avoidable mortality: a study in Valencia, Spain, 1975-90.

Authors:  X Albert; A Bayo; J L Alfonso; P Cortina; D Corella
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

5.  Implementation of Fetal and Infant Mortality Review (FIMR): experience from the national Healthy Start program.

Authors:  M Baltay; M C McCormick; P H Wise
Journal:  Matern Child Health J       Date:  1999-09

6.  Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study.

Authors:  Horst Wedekind; Thomas Bajanowski; Patrick Friederich; Günter Breithardt; Thomas Wülfing; Cornelia Siebrands; Birgit Engeland; Gerold Mönnig; Wilhelm Haverkamp; Bernd Brinkmann; Eric Schulze-Bahr
Journal:  Int J Legal Med       Date:  2005-07-13       Impact factor: 2.686

7.  Incidence and prevalence of non-specific symptoms and behavioural changes in infants under the age of two years.

Authors:  C O Holme
Journal:  Br J Gen Pract       Date:  1995-02       Impact factor: 5.386

8.  Is postnatal depression a risk factor for sudden infant death?

Authors:  C A Sanderson; B Cowden; D M B Hall; E M Taylor; R G Carpenter; J L Cox
Journal:  Br J Gen Pract       Date:  2002-08       Impact factor: 5.386

9.  Combined effect of infection and heavy wrapping on the risk of sudden unexpected infant death.

Authors:  R Gilbert; P Rudd; P J Berry; P J Fleming; E Hall; D G White; V O Oreffo; P James; J A Evans
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

10.  Contribution of long-QT syndrome genetic variants in sudden infant death syndrome.

Authors:  Gilles Millat; Béatrice Kugener; Philippe Chevalier; Mohamed Chahine; Hai Huang; Daniel Malicier; Claire Rodriguez-Lafrasse; Robert Rousson
Journal:  Pediatr Cardiol       Date:  2009-03-26       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.